Buscar
01/10/2024
FRAILTY SYNDROME IN ADULTS UNDERGOING AUTOLOGOUS HEMATOPOIETIC CELL TRANSPLANTATION. PROSPECTIVE STUDY ON BEHALF OF THE GRUPO ESPANOL DE TRASPLANTE HEMATOPOYETICO Y TERAPIA CELULAR (GETH-CT)
Salas, MQ, Solano, MT, Baile-Gonzalez, M, Acera-G mez, M, Fox, L, Perez-Artigas, MD, Santamar a, A, Quintela-Gonz lez, MD, S nchez-Salinas, A, Salmer n-Camacho, JM, Illana-Alvaro, V, Abdallahi-Lefdil, Z, Cornago-Navascues, J, Pardo, L, Fern ndez-Luis, S, Vega-Su rez, LP, Villar, S, Beorlegui-Murillo, P, Esquirol, A, Izquierdo-Garc a, I, Rodr guez-Gonz lez, S, Mussetti, A, Abuin-Blanco, A, Lopez-Mar n, J, Filarerro, S, Bento, L, Sureda, A. FRAILTY SYNDROME IN ADULTS UNDERGOING AUTOLOGOUS HEMATOPOIETIC CELL TRANSPLANTATION. PROSPECTIVE STUDY ON BEHALF OF THE GRUPO ESPANOL DE TRASPLANTE HEMATOPOYETICO Y TERAPIA CELULAR (GETH-CT). BONE MARROW TRANSPLANTATION. 2024; 59DOI:. PMID:. IF:5.200(Q1/1D).
01/09/2024
Midostaurin Plus Intensive Chemotherapy in FLT3-Mutated AML: "Real-Life" Data Versus the RATIFY Study
Bobes, A, Tormo, M, Diaz-Beya, M, Beneit, P, Botella, C, Moreno, AF, Mayol, AS, Sangerman, MA, Bermejo, AY, Amigo, MD, Labrador, J, Guinon, AG, Garrido, A, Serrano, J, Polo, SV, Fortes, MG, Sayas, MJ, Bergua, JM, Olave, MT, Vall-Llovera, F, Bargay, J, Sanchez, MP, Boyero, RG, Diaz-Lopez, A, de la Fuente, A. Midostaurin Plus Intensive Chemotherapy in FLT3-Mutated AML: "Real-Life" Data Versus the RATIFY Study. Clinical Lymphoma Myeloma & Leukemia. 2024; 24DOI:. PMID:. IF:2.700(Q2/4D).
13/08/2024
PTCy vs CNI-based GVHD prophylaxis in HLA-matched transplants for Hodgkin lymphoma: a study of the LWP of the EBMT
Montoro, J, Ngoya, M, Kulagin, A, Giebel, S, Broers, AEC, Bramanti, S, Halahleh, K, Pérez-Simón, JA, Solano, C, Ozcelik, T, Blaise, D, Sanz, J, Henriques, M, de Latour, RP, Martino, R, Scheid, C, Fox, L, Gromek, T, Jurado, M, Sakellari, I, Van Gorkom, G, Matteucci, P, Nagler, A, Koc, Y, Glass, B. PTCy vs CNI-based GVHD prophylaxis in HLA-matched transplants for Hodgkin lymphoma: a study of the LWP of the EBMT. Blood Advances. 2024; 8(15)DOI:10.1182/bloodadvances.2024013328. PMID:38810260. IF:7.100(Q1/2D).
01/01/2022
Risk factors analysis according to regional distribution of white matter hyperintensities in a stroke cohort
Medrano-Martorell, S, Capellades, J, Jimenez-Conde, J, Gonzalez-Ortiz, S, Vilas-Gonzalez, M, Rodriguez-Campello, A, Ois, A, Cuadrado-Godia, E, Avellaneda, C, Fernandez, I, Merino-Pena, E, Roquer, J, Marti-Fabregas, J, Giralt-Steinhauer, E. Risk factors analysis according to regional distribution of white matter hyperintensities in a stroke cohort. EUROPEAN RADIOLOGY. 2022; 32(1)DOI:10.1007/s00330-021-08106-2. PMID:34117555. IF:5.900(Q1/2D).
01/01/2022
The Role of Vascular Imaging atReferral Centers in the Drip and Ship Paradigm
Flores, A, Sero, L, Gomez-Choco, M, Ustrell, X, Pellise, A, Vinas, J, Rodriguez, P, Monterde, A, Castilho, G, Rubiera, M, Amaro, S, Padros, MAF, Cardona, P, Marti-Fabregas, J, Molina, CA, Serena, J, Jimenez-Fabrega, FX, Purroy, F, Zaragoza-Brunet, J, Cocho, D, Palomeras, E, Kuprinski, J, Mas, N, Hernandez-Perez, M, Sanjurjo, E, Carrion, D, Costa, X, Barcelo, M, Monedero, J, Catena, E, Rybyeba, M, Diaz, G, de la Ossa, NP, Ribo, M. The Role of Vascular Imaging atReferral Centers in the Drip and Ship Paradigm. Journal of Stroke & Cerebrovascular Diseases. 2022; 31(1)DOI:10.1016/j.jstrokecerebrovasdis.2021.106209. PMID:34794029. IF:2.500(Q3/7D).
01/12/2021
Influence of study design on effects of mask wearing on fMRI BOLD contrast and systemic physiology - A comment on Law et al. (2021)
Scholkmann, F, Fischer, JB, Frisk, LK, Delgado-Mederos, R, Mayos, M, Highton, D, Wolf, U, Wolf, M, Durduran, T. Influence of study design on effects of mask wearing on fMRI BOLD contrast and systemic physiology - A comment on Law et al. (2021). NEUROIMAGE. 2021; 244DOI:10.1016/j.neuroimage.2021.118549. PMID:34508896. IF:7.400(Q1/2D).
01/12/2021
Progression of Large Vessel Disease in Patients With Giant Cell Arteritis-Associated Ischemic Stroke: The Role of Vascular Imaging A Case Series
Guisado-Alonso, D, Edo, MC, Alarcon, PVE, Garcia-Sanchez, SM, Font, MA, Romo, LM, Marrero-Gonzalez, P, Mengual, JJ, Castrillo, L, Montull, C, Corominas, H, Gomez-Choco, M. Progression of Large Vessel Disease in Patients With Giant Cell Arteritis-Associated Ischemic Stroke: The Role of Vascular Imaging A Case Series. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY. 2021; 27(8)DOI:10.1097/RHU.0000000000001498. PMID:32732523. IF:3.902(Q3/6D).
01/11/2021
Characteristics and Outcomes of Patients With Cerebral Venous Sinus Thrombosis in SARS-CoV-2 Vaccine-Induced Immune Thrombotic Thrombocytopenia
van Kammen, MS, de Sousa, DA, Poli, S, Cordonnier, C, Heldner, MR, van de Munckhof, A, Krzywicka, K, van Haaps, T, Ciccone, A, Middeldorp, S, Levi, MM, Hovinga, JAK, Silvis, S, Hiltunen, S, Mansour, M, Arauz, A, Barboza, MA, Field, TS, Tsivgoulis, G, Nagel, S, Lindgren, E, Tatlisumak, T, Jood, K, Putaala, J, Ferro, JM, Arnold, M, Coutinho, JM, Guisado-Alonso D., Cerebral Venous Sinus Thrombosis T. Characteristics and Outcomes of Patients With Cerebral Venous Sinus Thrombosis in SARS-CoV-2 Vaccine-Induced Immune Thrombotic Thrombocytopenia. JAMA Neurology. 2021; 78(11)DOI:10.1001/jamaneurol.2021.3619. PMID:34581763. IF:29.907(Q1/1D).